Source: http://betacell-cellbio.eu/publications/publications_group.html
Timestamp: 2019-04-23 04:53:44+00:00

Document:
Fezoua-Boubegtiten,Z; Hastoy, B; Scotti, PA; Milochau, A; Bathany, K; Desbat,B; Castano,S; Oda,R; Lang, J, The transmembrane domain of the SNARE protein VAMP2 is highly sensitive to its lipid environment. BBA Biomembranes, in press.
Pirog, A., Y. Bornat, R. Perrier, M. Raoux, M. Jaffredo, A. Quotb, J. Lang, N. Lewis, and S. Renaud, Multimed: an integrated, multi-application platform for the real-time recording and sub-millisecond processing of biosignals. Sensors, 2018, 18(7), 2099.
Perrier R., A. Pirog, M. Jaffredo, J. Gaitan, B. Catargi, S. Renaud, M. Raoux, and J. Lang. Bioelectronic organ-based sensor for microfluidic real-time analysis of the demand in insulin. Biosensors and Bioelectronics, 2018. 117, 253-259.
Jeandidier, N., L. Chaillous, S. Franc, P.Y. Benhamou, P. Schaepelynck, H. Hanaire, B. Catargi, A. Farret, P. Fontaine, B. Guerci, Y. Reznik, A. Penfornis, S. Borot, P. Serusclat, Y. Kherbachi, G. D'Orsay, B. Detournay, P. Simon, and G. Charpentier (2018) DIABEO App Software and Telemedicine Versus Usual Follow-Up in the Treatment of Diabetic Patients: Protocol for the TELESAGE Randomized Controlled Trial. JMIR Res Protoc, 7: p. e66.
Cosson, E., B. Catargi, G. Cheisson, S. Jacqueminet, C. Ichai, A.M. Leguerrier, A. Ouattara, I. Tauveron, E. Bismuth, D. Benhamou, and P. Valensi (2018) Practical management of diabetes patients before, during and after surgery: A joint French diabetology and anaesthesiology position statement. Diabetes Metab, 44: p. 200-216.
Borot, S., P.Y. Benhamou, C. Atlan, E. Bismuth, E. Bonnemaison, B. Catargi, G. Charpentier, A. Farret, N. Filhol, S. Franc, D. Gouet, B. Guerci, I. Guilhem, C. Guillot, N. Jeandidier, M. Joubert, V. Melki, E. Merlen, A. Penfornis, S. Picard, E. Renard, Y. Reznik, J.P. Riveline, S. Rudoni, P. Schaepelynck, A. Sola-Gazagnes, N. Tubiana-Rufi, O. Verier-Mine, and H. Hanaire (2018) Practical implementation, education and interpretation guidelines for continuous glucose monitoring: A French position statement. Diabetes Metab, 44: p. 61-72.
Hastoy, B., P. A. Scotti, A. Milochau, Z. Fezoua-Boubegtiten, J. Rodas, R. Megret, B. Desbat, M. Laguerre, S. Castano, D. Perrais, P. Rorsman, R. Oda and J. Lang (2017). A Central Small Amino Acid in the VAMP2 Transmembrane Domain Regulates the Fusion Pore in Exocytosis. Scientific Reports. 2017, 7: 2835.
Mendoza, O., P. Calmet, I. Alves, S. Lecomte, M. Raoux, C. Cullin, and J. Elezgaray, A tensegrity driven DNA nanopore. Nanoscale, 2017. 9: p. 9762-9769.
A. Ravaud, C. de la Fouchardiere, P. Caron, A. Doussau, C. Do Cao, J. Asselineau, P. Rodien, D. Pouessel, P. Nicolli-Sire, M. Klein, C. Bournaud-Salinas, J.L. Wemeau, A. Gimbert, M.Q. Picat, D. Pedenon, L. Digue, A. Daste, B. Catargi, J.P. Delord, A multicenter phase II study of sunitinib in patients with locally advanced or metastatic differentiated, anaplastic or medullary thyroid carcinomas: mature data from the THYSU study, Eur J Cancer, 76 (2017) 110-117.
B. Neal, V. Perkovic, K.W. Mahaffey, D. de Zeeuw, G. Fulcher, N. Erondu, W. Shaw, G. Law, M. Desai, D.R. Matthews, Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes, N Engl J Med, 377 (2017) 644-657.
S. Lassalle, J. Zangari, A. Popa, M. Ilie, V. Hofman, E. Long, M. Patey, F. Tissier, G. Belleannee, H. Trouette, B. Catargi, I. Peyrottes, J.L. Sadoul, O. Bordone, C. Bonnetaud, C. Butori, A. Bozec, N. Guevara, J. Santini, I.S. Henaoui, G. Lemaire, O. Blanck, P. Vielh, P. Barbry, B. Mari, P. Brest, P. Hofman, MicroRNA-375/SEC23A as biomarkers of the in vitro efficacy of vandetanib, Oncotarget, 7 (2016) 30461-30478.
S. Denisov, F. Pinaud, M. Chambaud, V. Lapeyre, B. Catargi, N. Sojic, N. McClenaghan, V. Ravaine, Saccharide-induced modulation of photoluminescence lifetime in microgels, Physical Chemistry Chemical Physics, 18 (2016) 16812-16821.
Solomou, A., E. Philippe, P. Chabosseau, S. Migrenne-Li, J. Gaitan, J. Lang, C. Magnan, and G.A. Rutter. Over-expression of Slc30a8/ZnT8 selectively in the mouse alpha cell impairs glucagon release and responses to hypoglycemia. Nutr Metab (Lond). 2016, 13:46.
Pedraza E, Karajić A, Raoux M, Perrier R, Lebreton F, Arbault S, Gaitan J, Renaud S, Kuhn A, Lang, J . Guiding pancreatic beta-cells to target electrodes in a whole-cell biosensor for diabetes.Lab Chip, 2015, DOI: 10.1039/C5LC00616C.
Verges, B. Patois-Verges, M.C. Iliou, I. Simoneau-Robin, J.H. Bertrand, J.M. Feige, H. Douard, B. Catargi, M. Fischbach, Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study, BMC Cardiovasc Disord, 15 (2015) 64.
F. Pinaud, R. Millereux, P. Vialar-Trarieux, B. Catargi, S. Pinet, I. Gosse, N. Sojic, V. Ravaine, Differential Photoluminescent and Electrochemiluminescent Behavior for Resonance Energy Transfer Processes in Thermoresponsive Microgels, J Phys Chem B, 119 (2015) 12954-12961.
M.A. Pfeffer, B. Claggett, R. Diaz, K. Dickstein, H.C. Gerstein, L.V. Kober, F.C. Lawson, L. Ping, X. Wei, E.F. Lewis, A.P. Maggioni, J.J. McMurray, J.L. Probstfield, M.C. Riddle, S.D. Solomon, J.C. Tardif, Lixisenatide in Patients with Type 2 Diabetes and Acute Coronary Syndrome, N Engl J Med, 373 (2015) 2247-2257.
Milochau, A., Lagrée, V., Bennassy, M.N., Papin, J., Lajoix, A., Chaignepain, S., Garcia-Arcos, I., Schmitter, J.M., Ochoa, B. and Lang, J. Synaptotagmin 11 interacts with components of the RNA-induced silencing complex RISC in clonal pancreatic ß-cells. FEBS Lett. 2014, 588:2217-2222.
L. Messager, N. Portecop, E. Hachet, V. Lapeyre, I. Pignot-Paintrand, B. Catargi, R. Auzély-Velty, V. Ravaine, Photochemical crosslinking of hyaluronic acid confined in nanoemulsions: towards nanogels with a controlled structure, Journal of Materials Chemistry B, 1 (2013) 3369-3379.
Raoux, M., Bornat, Y., Quotb, A., Catargi, B., Renaud, S. and Lang , J. Non-invasive long-term and real-time analysis of endocrine cells on micro-electrode arrays. J. Physiol. 2012, 590:1085-1092.
B. Verges, A. Avignon, F. Bonnet, B. Catargi, S. Cattan, E. Cosson, G. Ducrocq, M. Elbaz, A. Fredenrich, P. Gourdy, Consensus statement on the care of the hyperglycaemic/diabetic patient during and in the immediate follow-up of acute coronary syndrome, Diabetes & Metabolism, 38 (2012) 113-127.
J.-P. Riveline, P. Schaepelynck, L. Chaillous, E. Renard, A. Sola-Gazagnes, A. Penfornis, N. Tubiana-Rufi, V. Sulmont, B. Catargi, C. Lukas, Assessment of patient-led or physician-driven continuous glucose monitoring in patients with poorly controlled type 1 diabetes using basal-bolus insulin regimens, Diabetes Care, 35 (2012) 965-971.
A. Quotb, Bornat Y, Raoux M, Lang J, Renaud S. NeuroBetaMed: A re-configurable wavelet-based event detection circuit for in vitro biological signals. 2012 IEEE International Symposium on Circuits and Systems (ISCAS), Seoul, Korea (South). 2012.
Riveline JP, Schaepelynck P, Chaillous L, Renard E, Sola-Gazagnes A, Penfornis A, Tubiana-Rufi N, Sulmont V, Catargi B, Lukas C, Radermecker RP, Thivolet C, Moreau F, Benhamou PY, Guerci B, Leguerrier AM, Millot L, Sachon C, Charpentier G, Hanaire H; for the EVADIAC Sensor Study Group. 2012. Assessment of Patient-Led or Physician-Driven Continuous Glucose Monitoring in Patients With Poorly Controlled Type 1 Diabetes Using Basal-Bolus Insulin Regimens: A 1-year multicenter study. Diabetes Care. 2012 Mar 28.
P.-Y. Benhamou, B. Catargi, B. Delenne, B. Guerci, H. Hanaire, N. Jeandidier, R. Leroy, L. Meyer, A. Penfornis, R.-P. Radermecker, Real-time continuous glucose monitoring (CGM) integrated into the treatment of type 1 diabetes: consensus of experts from SFD, EVADIAC and SFE, Diabetes & metabolism, 38 (2012) S67-S83.
Roger, B. *, J. Papin *, P. Vacher, M. Raoux, A. Mulot, M. Dubois, B.H. Vanderwalle, F. Pattou, G. Charpentier, J.C. Jonas, N. Moustaid-Moussa, and J. Lang, Adenylyl cyclase 8 is central to glucagon-like peptide 1 signalling and effects of chronically elevated glucose in rat and human pancreatic beta cells. Diabetologia, 2011, 54:390-402.
Yassine, W., A. Milochau, S. Buchoux, J. Lang, B. Desbat, and R. Oda, Effect of monolayer lipid charges on the structure and orientation of protein VAMP1 at the air-water interface. Biochem. Biophys. Acta – Biomembranes, 2010, 1798:928-937.
Lapeyre, V., C. Ancla, B. Catargi, and V. Ravaine, Glucose-responsive microgels with a core-shell structure. J. Colloid Interface Sci., 2008. 327: 316-23.
Jeandidier, N., J.P. Riveline, N. Tubiana-Rufi, A. Vambergue, B. Catargi, V. Melki, G. Charpentier, and B. Guerci, Treatment of diabetes mellitus using an externalinsulin pump in clinical practice. Diabetes Metab., 2008. 34: 425-38.
Grise, F., N. Taib, C. Monterrat, V. Lagrée, and J. Lang, Distinct roles of the C2A and the C2B domain of the vesicular Ca2+ sensor synaptotagmin 9 in endocrine ß-cells. Biochem. J., 2007, 403: p. 483-492.
Monterrat, C., F. Grise, A. Hémar, and J. Lang, The calcium-sensing protein synaptotagmin 7 is expressed on different endosomal compartments in pancreatic ß-cells and in neurons but not on large dense core vesicles. Histochem. Cell Biol., 2007,127: 625-632.
Dubois, M., P. Vacher, B. Roger, D. Huyghe, B. Vandewalle, J. Kerr-Conte, F. Pattou, N. Moustaïd Moussa, and J. Lang, Glucotoxicity inhibits late steps of insulin exocytosis. Endocrinology, 2007. 148: p.1605-1614.
Lajus, S. and J. Lang, Splice variant 3, but not 2 of receptor protein-tyrosine phosphatase sigma can mediate stimulation of insulin-secretion by alpha-latrotoxin. J. Cell Biochem., 2006. 98: p. 1552-1559.
Monterrat, C., F. Boal, F. Grise, A. Hemar, and J. Lang, Synaptotagmin 8 is expressed both as a calcium-insensitive soluble and membrane protein in neurons, neuroendocrine and endocrine cells. Biochem. Biophys. Acta - Mol. Cell Res., 2006. 1763: p. 73-81.
Dufaitre-Patouraux, L., et al., Continuous intraperitoneal insulin infusion does not increase the risk of organ-specific autoimmune disease in type 1 diabetic patients:results of a multicentric, comparative study. Diabetes Metab., 2006. 32: 427-32.
Tabarin, A., et al., Resistance to diet-induced obesity in mu-opioid receptor-deficient mice: evidence for a "thrifty gene". Diabetes, 2005. 54: 3510-6.
Gatta, B., D.H. Hau, B. Catargi, P. Roger, and A. Tabarin, Re-evaluation of the efficacy of the association of cabergoline to somatostatin analogues in acromegalic patients. Clin Endocrinol (Oxf), 2005. 63: 477-8.
Boal, F., H. Zhang, C. Tessier, P. Scotti, and J. Lang, The variable C-terminus of cysteine string proteins modulates exocytosis and protein-protein interactions. Biochemistry, 2004. 43: p. 16212-16223.
Nguyen, Q.V., Caro, A., Raoux, M., Quotb, A., Floderer, J.B., Bornat, Y., Renaud, S. and Lang, J. (2013). A novel bioelectronic glucose sensor to process distinct electrical activities of pancreatic beta-cells. Conf Proc IEEE Eng Med Biol Soc 2013, 172-175.
Bornat, Y.; Raoux, M.; Boutaib, Y.; Morin, F. O.; Charpentier, G.; Lang, J.; Renaud, S. Detection of electrical activity of pancreatic ß-cells using micro-electrode arrays. Proceedings 5th IEEE Int. Symposium on Electronic Design, Test & Applications, in press.
B. Hastoy, A. Clark, P. Rorsman, J. Lang, Fusion pore in exocytosis: more than an exit gate? A b-cell perspective, Cell Calcium 2017, 68: 45-61.
Raoux, M., G. Bontorin, Y. Bornat, J. Lang, and S. Renaud, Bioelectronic sensing of insulin demand, in Biohybrid Systems, R. Jung, Editor. 2011, Wiley-VCH.
Rigalleau, V., J. Lang, and H. Gin, Etiologie et physiopathologie du diabète de type 2. Encyclopédie Médico-chirurgicale, 2007.
Lang, J., Seconds messagers et exocytose. Médecine Clinique - Endocrinologie et Diabète, 2006. Nov 2006: p. 15-21.
Lang, J., PIPs and pools in insulin secretion. Trends Endocrinol. Metab., 2003. 14: p. 297-299.
Raoux, M., G. Bontorin, Y. Bornat, J. Lang, and S. Renaud, Bioelectronic sensing of insulin demand, in Biohybrid Systems, R. Jung, Editor. in press, Wiley-VCH.

References: V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V. 
 V.